ClinicalTrials.Veeva

Menu

Microvascular Changes in OCT-angiography in Type 1 Diabetes Mellitus at the Onset of the Disease and After Optimization of Glycemic Control.

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Enrolling

Conditions

Type 1 Diabetes
Diabetic Retinopathy

Treatments

Diagnostic Test: Optical Coherence Tomography (OCT) Angiography

Study type

Observational

Funder types

Other

Identifiers

NCT04888598
IIBSP-RET-2020-69

Details and patient eligibility

About

The objective of the study is to evaluate the differences in the retinal microcirculation measured by OCT-Angiography in patients with type 1 diabetes between the diagnosis of the disease and after 3 months of insulin treatment.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with Type 1 Diabetes at diagnosis of the disease (less than 7 days after diagnosis)
  • Age equal to or greater than 18 years
  • Signature of the informed consent by the patient / legal guardian.

Exclusion criteria

  • Metabolic situation of ketosis or ketoacidosis, according to clinical criteria established in the protocol of the Endocrinology and Nutrition Service. The patient will be a candidate once the ketonemia is absent (value <1 mmol / L).
  • Previous diagnosis of dyslipidemia and any previous lipid-lowering treatment
  • Previous diagnosis of hypertension and any previous hypotensive treatment
  • Previous diagnosis of any form of cardiovascular disease, including heart failure.
  • Previous kidney disease, and presence of advanced kidney failure (estimated glomerular filtration rate <60 ml / min)
  • Presence of diabetic retinopathy identifiable by conventional eye fundus or retinography, or other concomitant retinal vascular pathology (hypertensive retinopathy, venous occlusion, arterial obstruction, etc.)
  • History or presence of retinal pathology that may alter its structure and / or the validity of the measurements (retinal detachment, epiretinal membrane, high myopia -understood as an axial length greater than or equal to 26mm measured by "IOL Master" biometry-, neovascular membrane, choroidal tumors, etc.)
  • History of posterior uveitis or retinal vasculitis
  • Glaucoma and neuro-ophthalmological pathology that can alter the neuroretinal structures.
  • Refractive media opacity that prevents a correct acquisition of images and, therefore, their evaluation
  • Dementia or intellectual disability that prevent proper collaboration when acquiring images

Trial design

20 participants in 1 patient group

Type 1 diabetic patients
Description:
Recently diagnosed type 1 diabetes patients
Treatment:
Diagnostic Test: Optical Coherence Tomography (OCT) Angiography

Trial contacts and locations

2

Loading...

Central trial contact

Ignacio Salvador, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems